Third, Kaul et al. [58] observed that the signature low-grade glioma oncoprotein, the KIAA1549::BRAF fusion, reactivates RHEB by ERK mediated phosphorylation of TSC1/2 and thereby elevates mTOR signaling [58]. Here, BRAF is linked to central nervous system cancer.